Highlights Sareum Holdings plc

Stocks

SAR

GB00BMC3RJ87

Biotechnology & Medical Research

Market Closed - London S.E. Other stock markets 11:35:17 2026-06-11 am EDT			5-day change	1st Jan Change
23.00 ^GBX	0.00%		-2.13%	+53.33%

Apr. 15	WINNERS & LOSERS: Oracle Power shines; Ferrexpo output plunges	AN
Mar. 13	Sareum Holdings plc, H1 2026 Earnings Call, Mar 12, 2026

Highlights

Mar. 12	Sareum Holdings plc Reports Earnings Results for the Half Year Ended December 31, 2025	CI
Feb. 17	Sareum Holdings plc Restart of Phase 2-Enabling Toxicology Programme for SDC-1801	CI
25-10-23	Sareum Holdings plc Reports Earnings Results for the Full Year Ended June 30, 2025	CI
25-10-23	Sareum Holdings plc Provides Update on Operational Activities and Pipeline Progress	CI
25-10-10	Sareum Holdings plc Announces Update on Toxicology Study for SDC-1801	CI
25-08-12	Sareum shares climb on partnership with AI-driven drug discovery firm	AN
25-08-12	Sareum, Receptor.AI Partner to Develop New Drugs for Neuroinflammatory Conditions	MT
25-08-12	Sareum Holdings plc Announces Collaboration with Receptor.AI to Accelerate Discovery of TYK2/JAK1 Inhibitors for Neuroinflammatory Diseases	CI
25-05-29	Sareum Holdings plc Announces Initiation of Toxicology Studies for Lead TYK2/JAK1 Inhibitor, SDC-1801	CI
25-04-28	Sareum Reports 'Significant Potential' of TYK2/JAK1 Inhibitors, Gains Full Control of Cancer Cell Therapy	MT
25-04-28	Sareum Holdings plc Provides an Update on Its TYK2/JAK1 and SRA737 Programmes	CI
25-04-24	Sareum to Issue Shares Under Warrant Exercise	MT
25-03-25	Sareum Holdings plc Reports Earnings Results for the Half Year Ended December 31, 2024	CI
25-03-13	Sareum Holdings Acquires Licence For SRA737	RE
24-12-31	Sareum served notice on commercial licence for cancer treatment	AN
24-12-31	Sareum's Development Partner Receives License Termination Notice for Cancer Treatment Product	MT
24-12-31	Sareum Holdings plc Provides an Update on the Status of SRA737	CI
24-10-29	Sareum annual loss widens as remains focused on autoimmune diseases	AN
24-10-29	Earnings Flash (SAR.L) SAREUM HOLDINGS Posts FY24 Loss GBX-4.20	MT
24-10-29	Sareum Holdings plc Reports Earnings Results for the Full Year Ended June 30, 2024	CI
24-10-21	Sareum raises further GBP1.0 million via subscription	AN
24-10-21	Sareum Raises GBP1 Million Via Share Issuance	MT
24-10-11	Sareum Holdings completes GBP2.4 million fundraise to boost lead asset	AN
24-10-11	Sareum Raises GBP2 Million for Autoimmune Disease Drug Development	MT
24-09-16	Sareum receives patent allowance for crystalline SDC-1801 in China	AN